Table 1 Clinical characteristics of patients with BC (TCGA, n = 874).

From: Exploring the prognostic value of S100A11 and its association with immune infiltration in breast cancer

Clinical factor

Alive(n = 745)

Dead(n = 129)

Total(n = 874)

Age

 Median[min, max]

57[26,89]

61[26,89]

57.5[26,89]

Gender (n(%))

 Female

735

128

863 (98.74)

 Male

10

1

11 (1.26)

Stage (n(%))

 Stage I

144(19.3)

15 (11.6)

159 (18.2)

 Stage II

446 (59.9)

60 (46.5)

506 (57.9)

 Stage III

152 (20.4)

39 (30.2)

191 (21.9)

 Stage IV

3 (0.4)

15 (11.6)

18 (2.1)

T (n(%))

 T1

208 (27.9)

27 (20.9)

235 (26.9)

 T2

443 (59.5)

69 (53.5)

512 (58.6)

 T3

77 (10.3)

20 (15.5)

97 (11.1)

 T4

17 (2.3)

13 (10.1)

30 (3.4)

M (n(%))

 M0

742 (99.6)

114 (88.4)

856 (97.9)

 M1

3 (0.4)

15 (11.6)

18 (2.1)

N (n(%))

 N0

383 (51.4)

41 (31.85)

424 (48.5)

 N1

244 (32.8)

55(42.6)

299 (34.2

 N2

77 (10.3)

19(14.7)

96 (11.0)

 N3

41 (5.5)

14(10.9)

55 (6.3)